Prof David Ritchie
Honorary (Professorial Fellow)
Department of Medicine
525 Scholarly works
13 Projects
HIGHLIGHTS
2026
Journal article
Subtherapeutic posaconazole exposure during delayed-release tablet prophylaxis in high-risk patients with haematological malignancies: rationale for routine therapeutic drug monitoring
DOI: 10.1093/jac/dkag2332026
Journal article
Marginal Zone Lymphoma is associated with dysregulated T cell immunity which is not altered by ibrutinib-venetoclax treatment
DOI: 10.1016/j.bneo.2026.1002602026
Journal article
Identification of T:B Cell Multimers After Bispecific T Cell Engagement, Using Both Conventional and Imaging Flow Cytometry
DOI: 10.1002/cyto.a.700392026
Journal article
Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignancies
DOI: 10.1016/S2352-3026(26)00005-02021
Research grants (ARC, NHMRC, MRFF)
Diagnosis, Discovery and Novel Phenotype Characterisation Using Multimodal Genomics in Patients With Inherited Bone Marrow Failure and Related Disorders
2021
Research grants (ARC, NHMRC, MRFF)
Repurposing BCL-2 Inhibitors for Immune Manipulation to Improve Outcomes in Allogeneic Stem Cell Transplantation
2018
Research Grant
Inhibiting BCL-2 and Nk Cells Improves Stem Cell Transplant Outcomes in Acute Myeloid Leukaemia
RECENT SCHOLARLY WORKS
2026
Journal article
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
DOI: 10.1182/bloodadvances.20250166462026
Journal article
QuantiFERON-CMV Monitoring Post-Allogeneic Hematopoietic Stem Cell Transplantation Is Dynamic and Predictive of Immediate Cytomegalovirus Outcomes
DOI: 10.1111/tid.701522026
Journal article
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
DOI: 10.1080/10428194.2025.25797212026
Journal article
T cell and monocyte activation in concert with hematopoietic stem cell interactions shapes the post-allogeneic transplant immune landscape in poor graft function
DOI: 10.3389/fimmu.2026.17500932026
Journal article
Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS
DOI: 10.1038/s41409-026-02874-52026
Journal article
KRAS internal tandem duplications and alternative driver variants in BRAF Val600Glu negative hairy cell leukemia
DOI: 10.1080/10428194.2026.2615055
RECENT PROJECTS
2026
Research contracts (non-grants)
Developing Translational Insights Into Poor Graft Function Following Allogeneic Stem Cell Transplantation
2025
Research grants (ARC, NHMRC, MRFF)
Personalised Haematopoietic Stem Cells, Moving Transplantation Into the 21st Century